This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

David E. Schuller, MD; Hussein Abou-Issa, PhD; Robert Parrish, MD

Arch Otolaryngol. 1984;110(11):725-727.

Abstract
• The existence of hormone receptors on or within neoplastic tissue has potential diagnostic, therapeutic, and prognostic importance. It was the purpose of this study to measure estrogen and progesterone receptors in a large group of patients with head and neck cancer to determine their frequency. Sixty-five patients with head and neck tumors underwent a total of 75 estrogen and 50 progesterone receptor assays. In this group, 87.7% were squamous cell carcinoma. In the estrogen receptor assays, 89.3% (67/75) were negative, 8% (6/75) were borderline, and only 2.7% (2/75) were positive. In the progesterone receptor assays, 78% (39/50) were negative, 22% (11/50) were borderline, and there were no positive results. There were no changes in assays of tissue removed at biopsy v tissue removed during surgery. There was no impact with chemotherapy. In conclusion, head and neck cancers do not appear to possess estrogen or progesterone receptors and can be considered to be hormonally independent.

(Arch Otolaryngol 1984;110:725-727)

Author Affiliations
From the Departments of Otolaryngology (Drs Schuller and Parrish) and Surgery (Dr AbouIssa), Ohio State University, Columbus.

Footnotes
Accepted for publication June 18, 1984.

Read before the American Society for Head and Neck Surgery, Palm Beach, Fla, May 10, 1984.

Reprint requests to Department of Otolaryngology, Ohio State University, 456 Clinic Dr, Columbus, OH 43210 (Dr Schuller).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Cross-Talk between Estrogen Receptor and Epidermal Growth Factor Receptor in Head and Neck Squamous Cell Carcinoma
Egloff et al.
Clin. Cancer Res. 2009;15:6529-6540.
ABSTRACT | FULL TEXT  

Detection of estrogen receptor by immunohistochemistry in pulmonary adenocarcinoma
Dabbs et al.
Ann. Thorac. Surg. 2002;73:403-406.
ABSTRACT | FULL TEXT  

Growth Effects of Tamoxifen and Estradiol on Laryngeal Carcinoma Cell Lines
Robbins et al.
Arch Otolaryngol Head Neck Surg 1994;120:1261-1266.
ABSTRACT  

Sex Steroid Receptor Distribution in the Human Larynx and Laryngeal Carcinoma
Ferguson et al.
Arch Otolaryngol Head Neck Surg 1987;113:1311-1315.
ABSTRACT  

Estrogen Receptors in Normal Salivary Gland and Salivary Gland Carcinoma
Dimery et al.
Arch Otolaryngol Head Neck Surg 1987;113:1082-1085.
ABSTRACT  

The Natural History, Pathogenesis, and Treatment of Juvenile Angiofibroma: Personal Experience With 44 Patients
Harrison
Arch Otolaryngol Head Neck Surg 1987;113:936-942.
ABSTRACT  

Growth Inhibition of Laryngeal UM-SCC Cell Lines by Tamoxifen: Comparison With Effects on the MCF-7 Breast Cancer Cell Line
Shapira et al.
Arch Otolaryngol Head Neck Surg 1986;112:1151-1158.
ABSTRACT